Baby, N., Faust, A. C., Smith, T., Sheperd, L. A., Knoll, L., & Goodman, E. L. (2017). Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia. Antimicrob Agents Chemother.
Chicago-stil citatBaby, Nidhu, Andrew C. Faust, Terri Smith, Lyndsay A. Sheperd, Laura Knoll, och Edward L. Goodman. "Nasal Methicillin-Resistant Staphylococcus Aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients With Suspected MRSA Pneumonia." Antimicrob Agents Chemother 2017.
MLA-referensBaby, Nidhu, et al. "Nasal Methicillin-Resistant Staphylococcus Aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients With Suspected MRSA Pneumonia." Antimicrob Agents Chemother 2017.